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Abstract
Background: The long time to diagnosis of medulloblastoma, one of the most frequent brain tumors in children, is the
source of painful remorse and sometimes lawsuits. We analyzed its consequences for tumor stage, survival, and sequelae.
Patients and Methods: This retrospective population-based cohort study included all cases of pediatric medulloblastoma
from a region of France between 1990 and 2005. We collected the demographic, clinical, and tumor data and analyzed the
relations between the interval from symptom onset until diagnosis, initial disease stage, survival, and neuropsychological
and neurological outcome.
Results: The median interval from symptom onset until diagnosis for the 166 cases was 65 days (interquartile range 31–121,
range 3–457). A long interval (defined as longer than the median) was associated with a lower frequency of metastasis in the
univariate and multivariate analyses and with a larger tumor volume, desmoplastic histology, and longer survival in the
univariate analysis, but not after adjustment for confounding factors. The time to diagnosis was significantly associated with
IQ score among survivors. No significant relation was found between the time to diagnosis and neurological disability. In
the 62 patients with metastases, a long prediagnosis interval was associated with a higher T stage, infiltration of the fourth
ventricle floor, and incomplete surgical resection; it nonetheless did not influence survival significantly in this subgroup.
Conclusions: We found complex and often inverse relations between time to diagnosis of medulloblastoma in children and
initial severity factors, survival, and neuropsychological and neurological outcome. This interval appears due more to the
nature of the tumor and its progression than to parental or medical factors. These conclusions should be taken into account
in the information provided to parents and in expert assessments produced for malpractice claims.
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Introduction
Brain tumors are the leading cause of solid cancers in children
[1]. Medulloblastoma, one of the most common types [1], has a
10-year survival rate of 50% [2–5], and many survivors have
neurological and cognitive sequelae [6,7]. The time to diagnosis
for brain tumors is one of the longest of all childhood cancers,
with a median ranging from 2 to 5 months [8–24]. We showed
recently that the time from symptom onset to diagnosis of
medulloblastoma is long (median 65 days), and we analyzed the
causes of this lengthy interval. In particular, it was significantly
associated with the presence of apparently psychological symp-
toms [25].
The delay in diagnosis of childhood tumors leads to painful
remorse or guilt feelings for parents and physicians, loss of
confidence and sometimes conflicts [26,27]. In some countries it is
a leading cause of pediatric malpractice suits [28]. Its precise
consequences, however, have been little studied [18]. The obvious
hypothesis is that the longer the tumor has to develop, the more
extensive it will be (higher stage), and therefore the poorer the
prognosis. Results thus far available in the literature tend to
contradict this hypothesis. Only two studies are available for
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e33415medulloblastoma specifically: one found no relation in either
direction between delay and survival [17], while the other reported
an inverse relation between duration of symptoms and metastasis
[13]. Nonetheless several factors limit the usefulness of these
results: the limited numbers (,100) of pediatric patients [13,17],
pooled analyses for pediatric and adult patients [13], single-center
recruitment subject to selection bias [13], incomplete initial disease
staging for some patients that increases the likelihood of
classification bias [13], a study period partially preceding the
availability of CT and MRI [13], and a lack of multivariate
analyses despite the presence of potential confounders [13,17].
Finally, none of these studies analyzed the relation between time to
diagnosis and either local tumor stage, complete surgical resection
or neurological and cognitive sequelae.
Our objective was therefore to analyze, in a pediatric
population-based study, the consequences of the time to diagnosis
of medulloblastoma on initial tumor stage, survival, and
neuropsychological and neurological outcome, while taking
confounding factors into account.
Methods
Patients
We conducted a multicenter historic population-based cohort
study that included all patients in one French region (Ile-de-
France, the Paris metropolitan region) who were younger than 15
years when diagnosed with a histologically-confirmed medullo-
blastoma from 1990 through 2005. The study has been described
in detail elsewhere [25]. The geographic exhaustiveness of the
recruitment was verified from the French National Registry of
Childhood Solid Tumors [29,30].
Data collected
We collected the following data from each medical file in the
neurosurgery and oncology departments: age, sex, symptoms, the
radiologic and pathology characteristics of the tumor (standard or
nodular/desmoplastic histology [31,32], the latter referred to
hereafter as desmoplastic), local and metastatic staging, postoper-
ative status (posterior fossa syndrome), vital status and neurological
outcome at last follow-up (full scale intelligence quotient (IQ) score
and neurological examination, classified into 3 groups: strictly
normal neurological examination; moderate and unilateral
dysmetria without functional consequence; or neurological
disability). Pathologists at each hospital (sites of the neurosurgery
and oncology departments) confirmed all histological diagnoses of
biopsy or resection samples within days of the radiological
diagnosis. The time to diagnosis, expressed in days, was defined
as the interval between the first symptom attributable to the
disease and the date of diagnosis (date of brain imaging). When
ambiguous (for 2% of patients), it was independently evaluated by
3 of the authors, who reached a consensus.
Tumor stage was assessed: (1) by cerebral MRI, before and
shortly after surgery, to determine the completeness of the
resection, (2) pre- or postoperative spinal MRI, and (3) a
postoperative lumbar puncture to look for metastasis. All patients
had a complete staging work-up, except one who died within
24 hours of surgery. Based on the surgical report and early
postoperative imaging, the initial disease stage was classified by the
T stage according to the Chang-Harisiadis classification [33,34]
and according to the classification of risk groups recognized by the
International Society of Pediatric Oncology: standard risk
(complete resection), local high risk (incomplete resection), and
metastatic high risk [11]. The tumor volume was calculated
according to the formula for the volume of an ellipsoid: 4p/
36(height6width6depth)/8. During the study period, patients
were treated with surgery, chemotherapy, and radiotherapy
according to the national or European protocols [3–5,35–37].
Statistical analyses
First, we described the demographic and tumor characteristics
and the time to diagnosis. Second, we studied the relation between
this prediagnosis interval and initial severity factors (metastasis,
tumor volume, T stage and completeness of resection) by
univariate (Kruskal-Wallis test) and multivariate analysis, taking
into consideration the cofactors of interest, by either stratification
or adjustment in a backward stepwise logistic regression model.
Third, we studied the relations between time to diagnosis, survival,
and neurological and neuropsychological outcome. These analyses
were performed first for the entire population (Kaplan-Meier
method and logrank test), then after stratification for the identified
prognostic factors, and finally by adjustment for the cofactors of
interest in a Cox model. One of the Cox models was constructed
by adjusting the relation between time to diagnosis and survival by
a propensity score for a long prediagnosis interval [38], calculated
by the logistic regression equation produced at stage 2. The time to
diagnosis was used as a binary variable after dichotomization
around the median or as a continuous variable (after testing
linearity). Age was dichotomized around 5 years, in view of the
difference in treatment around this age [4,5]. Statistical analyses
were performed with STATA (StataCorp.).
Ethics Statement
The Institutional Review Committee (Comite ´ de Protection des
Personnes Ile-de-France III) stated that ‘‘this research was found to
conform to scientific principles and ethical research standards and
to the laws and regulations of France’’ and specifically approved
this study. Written informed consent of the patients or their
parents was not judged necessary for this kind of retrospective
study. Data were anonymized before the clinical records were
included.
Results
Population, distribution of time to diagnosis
Examination of the diagnostic code lists showed 170 patients
eligible for this study. Of these 170 eligible files, 4 (2%) were lost or
incomplete. The analysis therefore concerned 166 patients, 72% of
whom were boys. Median age at the first symptom was 6 years
(interquartile range (IQR): 4–9) and 31% were younger than 5
years.
The patients had a local tumor in 62% (standard risk 40%, local
high risk 22%) and a metastatic tumor in 38% of cases. The
median tumor volume was 33 cm
3 (IQR 22–42). Staging showed
2% of the children had T1 local tumors, 27% T2, 15% T3A, 39%
T3B, and 17% T4. The surgeon observed fourth ventricle floor
invasion in 47% of the 161 cases for which surgery was performed.
Resection was complete in 52% of cases. The histologic type was
standard for 78%, desmoplastic for 22%, and large-cell anaplastic
for one patient (pooled with the ‘‘standard histology’’ patients for
subsequent analysis).
Time to diagnosis was determined in all cases. Its median was
65 days (IQR 31–121, range 3–457). We have previously
described its distribution in detail [25]. After dichotomization
(table 1), a prediagnosis interval greater than the median of 65
days (hereafter, a long interval or time to diagnosis) was associated
with a standard histologic type (vs desmoplastic) and with
psychological symptoms (such as impaired school performance,
behavioral problems, depression, or anxiety). The patients younger
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(median 55 vs 77 days, p=0.03), but after dichotomization
(table 1), an interval greater than the median of 65 days was not
statistically associated with an age older than 5 years (p=0.13).
Relations between time to diagnosis, tumor stage, and
cofactors
The children with metastatic disease had a significantly shorter
prediagnosis interval than those with local tumors (median 31 vs
91 days, p,10
24; figure 1, table 1). Overall, tumor volume was
significantly larger for the patients with a long time to diagnosis
(median tumor volume 34 vs 27 cm
3, p=0.002; table 2). We did
not find a statistically significant (p.0.2) association between time
to diagnosis and any of the other factors related to local extension
(T stage and fourth ventricle floor invasion) or completeness of
surgical resection.
For the 103 patients (62%) without metastatic disease (table 2),
we did not find a significant association between time to diagnosis
and local extension (volume, T stage, or fourth ventricle floor
infiltration). Similarly there was no association with the complete-
ness of surgical resection among the 102 who had surgery (that is,
prediagnosis interval did not differ for standard risk and high-risk
local tumors: 89 vs 92 days, p.0.2). For the 62 patients (38%) with
metastatic disease, local extension was significantly greater for long
prediagnosis intervals: the tumor volume was larger, the T stage
more advanced, and fourth ventricle floor infiltration more
frequent (table 2). Of the 58 patients with metastatic disease
who had surgery, the median prediagnosis interval was 26 days for
those with complete resection and 41 days for incomplete resection
(p=0.05).
After adjustment by logistic regression for all of the potentially
explanatory factors associated with a long prediagnosis interval in
the univariate analysis with a p value,0.2 (i.e., age older or
younger than 5 years, psychological symptoms, histologic type,
and metastasis), two factors were significantly and independently
associated with an interval longer than the median: psychological
symptoms (adjusted odds ratio (ORa)=2.5 [1.1–5.6]; p=0.03) and
the absence of metastasis (ORa=7.6 [3.6–16.4]; p,10
23). The
associations with age and histologic type were not statistically
significant after adjustment (table 1). The four variables above and
the exact coefficients of the logistic regression equation were used
to construct the propensity score for long time to diagnosis used
below.
Figure 1. Distribution of time to diagnosis according to the presence of metastatic disease (p,10
24).
doi:10.1371/journal.pone.0033415.g001
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cofactors
No patients were lost to follow-up. At the last follow-up, 96
patients (58%) were still alive. The median follow-up was 7 years
(IQR 5–12 years, range 3–17 years). All survival rates reported
below are 10-year rates. The survival of patients with a long time
to diagnosis was significantly better than that of patients with a
short prediagnostic interval (60 vs 47%, relative risk (RR)=1.8
[1.2, 2.8], p=0.02; figure 2). Survival rates were significantly
better for patients older than 5 years, those without metastatic
disease, those with desmoplastic tumors and those with complete
tumor resection (table 3).
After stratification by age, survival rates for the children
younger than 5 years were best for those with a long time to
diagnosis (67 vs 29%, RR=3.6 [1.4, 8.9], p=0.03); for those older
than 5 years, survival did not differ significantly according to the
length of this interval (57 vs 56%, RR=1.1 [0.6, 2.1], p.0.2).
Stratification by metastatic disease showed that survival for the
patients with metastatic tumors was 66% among those with a long
interval vs 38% for those with shorter ones, but this difference was
not statistically significant (RR=2.2 [0.8, 6.4], p=0.12); for
patients without metastatic disease, survival did not differ
significantly according to prediagnosis interval (62 vs 55%,
RR=1.1 [0.6, 2.3], p.0.2). After stratification by histologic type,
survival was better in the group with standard tumor histology
when their time to diagnosis was longer than the median (55 vs
42%, RR=1.8 [1.1, 3.1], p=0.02); in the group with a
desmoplastic tumor (36 patients), survival did not differ signifi-
cantly according to this duration (72 vs 71%, RR=1 [0.3, 3.7],
p.0.2). After stratification by completeness of the resection,
survival among the patients with incomplete resection or no
surgery was better for those with a long interval (54 vs 36%,
RR=2.0 [1.1, 3.8], p=0.02); for the patients with complete
resection, survival did not differ significantly according to time to
diagnosis (65 vs 57%, RR=1.5 [0.73, 3.1], p.0.2).
After adjustment in a Cox model for the covariables of interest
associated with survival in the univariate analysis with a p
value,0.20 (i.e., time to diagnosis, age, metastasis, histology, and
complete resection), only age older than 5 years was independently
associated with survival (adjusted relative risk (RRa)=1.7 [1.0,
2.8], p=0.04). Survival was not significantly associated with time
to diagnosis, metastasis, complete resection, or histologic type
(table 3). In two other models, supplementary adjustment for the
use of radiotherapy (upfront, delayed or omitted in some children
under 5), or for the propensity score did not significantly change
the relation between time to diagnosis and survival (RRa=1.6
[0.9, 2.8], p=0.10 and RRa=1.5 [0.8, 2.5], p=0.17, respective-
ly). Using time to diagnosis as a continuous variable did not
significantly change the results either.
Relations between time to diagnosis, IQ score, and
neurological disability
Postoperative posterior fossa syndrome was described for 23%
of the patients. The neurological examination of the 96 survivors
was strictly normal for 30% of patients, showed moderate and
unilateral dysmetria without functional consequence for 36%, and
neurological disability for 33%. The median IQ score for the 80
(83%) of the 96 survivors for whom the IQ score was available was
78 (IQR: 68–94; range 42–131).
Figure 2. Survival according to time to diagnosis (more or less
than the median of 65 days).
doi:10.1371/journal.pone.0033415.g002
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associated with a significantly shorter time to diagnosis (median 50
vs 75 days, p=0.02). The time to diagnosis was not significantly
different (p.0.2) between patients with normal neurological
findings, with moderate and unilateral dysmetria without func-
tional consequence, or with neurological disability (median 87 vs
72 vs 72 days, respectively). The IQ score was significantly
associated with the prediagnosis interval, both after linear
regression (figure 3, p=0.01), following transformation with a
fractional polynomial, and after adjustment for age, radiotherapy
dose, and the covariables mentioned above (p,0.05).
Discussion
Main results
We found complex and often inverse relations between a longer
time to diagnosis of medulloblastoma in children, the initial
severity factors, and survival. A long prediagnosis interval was
Table 3. Survival according to age, tumor characteristics, and time to diagnosis (TtD).
relative risk adjusted relative risk
Characteristics n 10-year survival [95% CI] p* [95% CI] p*
(total=166) (%) univariate analysis multivariate analysis
{
TtD,median (65 days) 83 47 1.8 [1.2, 2.8] 0.02 1.5 [0.8, 2.5] 0.17
$median 83 60
Age at diagnosis ,5 years 51 45 1.9 [1.2, 3.1] 0.007 1.7 [1.0, 2.8] 0.04
.5 years 115 57
Metastatic tumor
1 62 43 1.8 [1.1, 2.9] 0.01 1.3 [0.7, 2.2] 0.4
Localized tumor 103 59
Standard histology 130 48 2.1 [1.1, 4.1] 0.03 1.7 [0.9, 3.4] 0.12
Desmoplastic histology 36 72
Incomplete resection or no surgery 80 44 1.7 [1.1, 2 .7] 0.03 1.6 [0.9, 2.6] 0.09
Complete tumor resection 86 68
Tumor volume.median (33 cm
3) 83 53 1.1 [0.7, 1.8] 0.6 - -
,median 83 54
*Degree of significance of the Logrank test.
{Cox model with adjustment for the following covariables: TtD less than or more than the median of 65 days, age older or younger than 5 years, desmoplastico rn o t
histology, metastatic or localized tumor.
1One patient died within 24 h of surgery, before spinal MRI, and was thus excluded from the analysis.
doi:10.1371/journal.pone.0033415.t003
Figure 3. IQ score according to time to diagnosis (p,0.05, see text).
doi:10.1371/journal.pone.0033415.g003
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metastasis, desmoplastic histology, and longer survival in the
univariate analysis but not after adjustment. The time to diagnosis
was significantly associated with IQ score among survivors. No
significant relation was found between the time to diagnosis and
neurological disability. In the 62 patients with metastatic disease, a
long prediagnosis interval was associated with a more advanced T
stage, fourth ventricle floor invasion, and incomplete surgical
resection; it nonetheless did not influence survival significantly in
this subgroup.
Hypothesis
The inverse relation between time to diagnosis and severity of
disease may be explained by the type of tumor progression.
Rapidly growing and metastatic tumors might produce swift and
intense clinical signs, leading to rapid consultation and diagnosis,
but for a very advanced tumor. Inversely, local tumors that grow
slowly might cause relatively mild and very progressive clinical
signs that would lead to a long period of development before
diagnosis. Recent studies of patients with medulloblastoma
indicate that outcome is determined much more by underlying
molecular biology [39] than clinical factors such as time to
diagnosis.
Study limitations
Our population-based cohort allowed us to avoid the recruit-
ment bias of single-center studies. The principal limitation of the
study is its retrospective nature. Nonetheless the data came from
multiple sources and the time to diagnosis was ambiguous for only
2% of patients. Disease extension was determined in all but one
patient (,1%), based on standardized measurement methods
(imaging). No patients were lost to follow-up. Most studies of time
to diagnosis are retrospective, which may lead to some bias, but it
is non-differential bias.
Our results are consistent with those of a previous study about
the relation between short prediagnostic intervals and metastasis
[13]: we confirmed their results in this more recent, larger and
exclusively pediatric population-based study that took confounding
factors into account and analyzed the consequences for initial
tumor stage and survival. Finally, we found the same demograph-
ic, clinical, tumor, and prognostic characteristics as in other series
of medulloblastoma in children [9–15,40].
Ethical and legal issues
The results of our study suggest that the time to diagnosis of
medulloblastoma is related more to the properties of the tumor
than to suboptimal care by either parents or healthcare personnel.
This information should reassure parents who feel guilty about the
delay until the first consultation for symptoms finally attributed to
the medulloblastoma, a delay sometimes attributable to their
psychological or banal nature [23,25]. Parents, in their quest to
determine the origin of the disease, feel remorse and guilt for
having neglected the initial symptoms, especially when the disease
outcome is unfavorable [26]. The diagnosis delay associated with
the physician is equally the source of painful regret [26] as well as
lawsuits [28]. Our study suggests that there is no simple causal
relation between time to diagnosis and harm or damage, even in
cases of metastasis, incomplete resection, or large tumor volume.
This finding is highly pertinent in a medical malpractice system
based on tort law [28], even if the complaint alleges specific acts, of
negligence for example, by the doctor rather than the length of the
delay alone. Moreover, the length of the diagnosis delay depends
on two separate factors: the patient delay, that is, the time interval
between the onset of symptoms and the first presentation to a
healthcare professional, and the doctor delay, that is, the time
interval between the first medical consultation and the final
diagnosis. In our study, the median duration of the latter was 30
days and accounted for slightly under half (46%) of the total delay.
However, because these data were available for only 40% of the
files, they were not analyzed in detail. Finally, the conclusions
about the individual consequences of a given diagnosis delay may
well differ from the conclusions drawn from the analysis of a
cohort of patients.
Conclusion
Although a longer time to diagnosis may not be related to
inferior prognosis, we cannot and do not claim that a ‘‘longer than
necessary’’ time to diagnosis will not lead to high-risk disease, need
for more intensive therapy, and possibly a worse outcome. The
inverse association between time to diagnosis and prognosis in a
group of patients does not mean that a delay in diagnosis can have
no consequences for an individual patient. Moreover, a rapid
diagnosis shortens children’s suffering and helps prevent parents’
loss of confidence in the health care system [26].
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